proxem.ai  ·  /solutions03 mandates
Mandates

What we do. And
deliberately, what we don't.

Three defined mandates. Fixed scope. Fixed partner. Delivered by a team of no more than four people, led by the partner who quoted the work.

Mandate A

AI Strategy
& Portfolio Review.

Commissioned by the CEO or board. A clinical review of every AI initiative against commercial merit, regulatory exposure, and organisational capacity to execute.

Typical buyer: CEO, CSO, board audit committee
Deliverables
A.01
Portfolio census

Every AI project, pilot, and vendor contract catalogued with owner, spend-to-date, and stated outcome.

A.02
Commercial merit scoring

Each initiative rated on cost base attacked, time to value, and defensibility of the resulting position.

A.03
Regulatory exposure map

AI Act risk classification, GDPR Article 22 implications, and sector rules per initiative.

A.04
Capability-to-execute audit

Honest assessment of data, talent, and organisational readiness, against what each initiative requires.

A.05
Kill list

A named set of initiatives recommended for decommission, with reasoning and a transition plan.

A.06
Twelve-month roadmap

What to fund, in what sequence, under what governance. Explicit about what we refuse to recommend.

Process

How the engagement runs.

Step 01 · Week 1–2
Scope & access

Partner-led kickoff. Access to finance, risk, IT, and business owners established under NDA. Working documents exchanged.

Step 02 · Week 3–5
Evidence collection

Structured interviews, contract review, and on-site observation. Findings logged against a live register, visible to the sponsor.

Step 03 · Week 6–8
Synthesis

Hypothesis tested against CFO, CIO, and general counsel. Dissent recorded. Recommendations adjusted or defended.

Step 04 · Week 9–10
Delivery

Board-session read-out. Written report with evidence annexes. Thirty-day follow-up to review adoption.

Mandate B

Governance
& EU AI Act Readiness.

For organisations operating high-risk or general-purpose AI systems under the EU AI Act. A control framework designed to be signed off by your general counsel, not ours.

Typical buyer: Chief Risk Officer, General Counsel, CIO
Deliverables
B.01
System classification register

Every deployed or planned system mapped to its AI Act risk tier and associated obligations.

B.02
Control framework

A documented set of controls for data, models, monitoring, and human oversight. Mapped to ISO 42001 where relevant.

B.03
Conformity assessment protocol

The internal process by which a new system is assessed, approved, and released into production.

B.04
Post-market monitoring plan

How performance and adverse events are tracked and reported to the regulator within statutory windows.

B.05
Roles & accountabilities chart

Named owners for each obligation. Reviewed with HR and legal. No ambiguity about who signs.

B.06
Board reporting template

A concise quarterly pack that satisfies the audit committee without generating new work.

Process

How the engagement runs.

Step 01 · Week 1–2
Regulatory baseline

Current obligations mapped against current practice. Gaps documented without hedging.

Step 02 · Week 3–6
Framework build

Controls drafted and pressure-tested with operators. Language aligned with existing policy hierarchy.

Step 03 · Week 7–10
Pilot & adjust

Framework applied to two live systems, end to end. Findings fed back into the control set.

Step 04 · Week 11–12
Sign-off

Framework tabled at risk committee. General counsel letter of adoption. Handover to internal owners.

Mandate C

Value Recovery
for Stalled Programmes.

For organisations that have spent two or three budget cycles on AI and cannot point to a P&L effect. We diagnose the reason, and either restore the programme or close it.

Typical buyer: CFO, CIO, Chief Transformation Officer
Deliverables
C.01
Spend reconciliation

Every euro committed to AI over the last three years, traced to a business outcome or to absence of one.

C.02
Root-cause diagnosis

A short written verdict, technical, organisational, commercial, or regulatory, with supporting evidence.

C.03
Restart or wind-down brief

Two costed options, honestly compared. The brief states which one we recommend.

C.04
Vendor renegotiation pack

Where contracts are the issue: a term sheet and negotiating position drafted with your procurement team.

C.05
90-day recovery plan

If restart is selected: a narrow, weekly-tracked plan with a named executive sponsor and a kill-switch date.

C.06
Quarterly review

Independent read-out to the sponsor and audit committee for the duration of the retainer.

/ engageresponse < 48h

The briefing comes
before the mandate.

We do not quote work without a 90-minute conversation with the people accountable. It is the only way to know whether we should take the mandate.